MX9205246A - Nuevos derivados de 3-cicloalquil-2-propenamida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que las contienen. - Google Patents

Nuevos derivados de 3-cicloalquil-2-propenamida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que las contienen.

Info

Publication number
MX9205246A
MX9205246A MX9205246A MX9205246A MX9205246A MX 9205246 A MX9205246 A MX 9205246A MX 9205246 A MX9205246 A MX 9205246A MX 9205246 A MX9205246 A MX 9205246A MX 9205246 A MX9205246 A MX 9205246A
Authority
MX
Mexico
Prior art keywords
compositions
contain
application
propenamide
salts
Prior art date
Application number
MX9205246A
Other languages
English (en)
Inventor
Elizabeth Anne Kuo
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919119874A external-priority patent/GB9119874D0/en
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MX9205246A publication Critical patent/MX9205246A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/40—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)

Abstract

La invención se refiere a los compuestos (I) en el cual R(1) representa H o alquilo, W representa O, S, SO o SO(2), Y y Z representan cada uno de ellos -CH- o uno de los dos representa -CH- y el otro es N, R(2), R(3), R(4), R(5), y R(6), que representan cada uno de ellos H, halógeno, OCH(3), SCH(3), alquilo, WCF(3), CF(3), NO(2), CN, W(CH(2))n-CF(3), W(CF(2))n-CF(3) y (CF(2))nCF(3), -(CH(2))n-CX(3) o R(3) y R(4) representan -O-CH(2)-O-, R(7) y R(8) representan H o alquilo y R(9) representa dicloalquilo, así como sus tautómeros y sus sales, su preparación y su aplicación como medicamentos.
MX9205246A 1991-09-17 1992-09-15 Nuevos derivados de 3-cicloalquil-2-propenamida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que las contienen. MX9205246A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119874A GB9119874D0 (en) 1991-09-17 1991-09-17 3-cylopropyl-prop-2-enamide derivatives
GB929213972A GB9213972D0 (en) 1991-09-17 1992-07-01 3-cycloalkyl-prop-2-enamide derivatives

Publications (1)

Publication Number Publication Date
MX9205246A true MX9205246A (es) 1994-06-30

Family

ID=26299550

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205246A MX9205246A (es) 1991-09-17 1992-09-15 Nuevos derivados de 3-cicloalquil-2-propenamida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que las contienen.

Country Status (19)

Country Link
US (2) US5312830A (es)
EP (1) EP0533573B1 (es)
JP (1) JP3145803B2 (es)
CN (1) CN1028863C (es)
AT (1) ATE145893T1 (es)
AU (1) AU649881B2 (es)
BR (1) BR9203643A (es)
CA (1) CA2078466C (es)
CZ (1) CZ281674B6 (es)
DE (1) DE69215625T2 (es)
DK (1) DK0533573T3 (es)
ES (1) ES2095434T3 (es)
FI (1) FI111248B (es)
GR (1) GR3022423T3 (es)
HU (1) HU210164B (es)
IL (1) IL102790A (es)
MX (1) MX9205246A (es)
NO (1) NO178299C (es)
NZ (1) NZ244329A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300083D0 (en) * 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
GB9520092D0 (en) * 1995-10-02 1995-12-06 Hoechst Roussel Ltd Chemical compounds
KR20160079123A (ko) 2013-11-22 2016-07-05 젠자임 코포레이션 신경변성 질병을 치료하기 위한 신규한 방법
WO2018144869A1 (en) * 2017-02-03 2018-08-09 The Regents Of The University Of California Compositons and methods for modulating uba5
US20200062696A1 (en) * 2017-02-03 2020-02-27 The Regents Of The University Of California Compositions and methods for inhibiting reticulon 4
GB2588707B (en) * 2019-08-21 2022-06-15 William Page Roland Improved containers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4414395A (en) * 1980-03-13 1983-11-08 Ciba-Geigy Corporation Process for the manufacture of hydrazono-isoindolines
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
EP0397052B1 (en) * 1989-05-09 1993-08-18 SDS Biotech K.K. Crotonic acid amide derivatives and insectides containing the same
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them

Also Published As

Publication number Publication date
NO923603D0 (no) 1992-09-16
CA2078466C (fr) 2003-04-15
NO178299C (no) 1996-02-28
DE69215625T2 (de) 1997-04-17
AU2451692A (en) 1993-03-18
CZ265392A3 (en) 1993-06-16
DE69215625D1 (de) 1997-01-16
CZ281674B6 (cs) 1996-12-11
DK0533573T3 (da) 1997-04-07
US5312830A (en) 1994-05-17
AU649881B2 (en) 1994-06-02
HU210164B (en) 1995-02-28
JPH05230008A (ja) 1993-09-07
BR9203643A (pt) 1993-04-13
FI924145A (fi) 1993-03-18
EP0533573A3 (fr) 1993-05-19
ATE145893T1 (de) 1996-12-15
ES2095434T3 (es) 1997-02-16
JP3145803B2 (ja) 2001-03-12
FI111248B (fi) 2003-06-30
HUT62555A (en) 1993-05-28
CA2078466A1 (fr) 1993-03-18
NO178299B (no) 1995-11-20
IL102790A (en) 1996-01-31
GR3022423T3 (en) 1997-04-30
CN1070637A (zh) 1993-04-07
NZ244329A (en) 1994-09-27
US5389652A (en) 1995-02-14
FI924145A0 (fi) 1992-09-16
NO923603L (no) 1993-03-18
CN1028863C (zh) 1995-06-14
EP0533573B1 (fr) 1996-12-04
IL102790A0 (en) 1993-01-31
HU9202942D0 (en) 1992-11-30
EP0533573A2 (fr) 1993-03-24

Similar Documents

Publication Publication Date Title
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
AR088808A2 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
ES2132351T3 (es) Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0462812T3 (da) Pyranderivater som inhibitorer af 5-lipoxygenase
AR044909A1 (es) Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
NO892579L (no) Heterocykliske forbindelser.
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
ES2062706T3 (es) Nuevos derivados de amino-metil-piperidina su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9205246A (es) Nuevos derivados de 3-cicloalquil-2-propenamida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que las contienen.
ATE10804T1 (de) Ein diphenylhydantoin-derivat enthaltende pharmazeutische zusammensetzung, verwendete derivate und ihre herstellung.
ES2115904T3 (es) Derivados amino ramificados del tiazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
HRP20040243B1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
ES2069841T3 (es) Nuevos derivados de imidazo-(1,2-c)-quinazolina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT92876A (pt) Processo de preparacao de derivados da benzonaftiridina-(1,8)
ES2078130T3 (es) Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
ES2045514T3 (es) Utilizacion de derivados del cromano para el tratamiento de los estados depresivos.
PT90815A (pt) Processo de preparacao de derivados da fenotiazina
ES2143159T3 (es) Nuevos derivados de 2-ciano-3-hidroxi-propenamidas que comprenden un radical trifluorometilsulfonilfenilo/trifluorometilsulfinilfenilo, procedimiento de preparacion, aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2115855T3 (es) Nuevos derivados de 17-iminometilalquenil-5-beta-14-beta-androstanos y 17-iminoalquil-5-beta,14-beta-androstanos, un procedimiento para su produccion y las composiciones farmaceuticas que los incluyen.
FI900650A0 (fi) Kalciumantagonister.
ES2101171T3 (es) Derivados de tiadiazol para el tratamiento de estados depresivos.
FR2609464B1 (fr) Nouveaux derives du n-(1h-indol 4-yl) benzamide ainsi que leurs sels, leur application a titre de medicaments, et les compositions les renfermant
ES2037855T3 (es) Procedimiento para preparar nuevos derivados de 1-bencil-2-oxo-5-alcoxi-pirrolidina.